Peer Review History
| Original SubmissionJuly 19, 2019 |
|---|
|
PONE-D-19-18607 In vitro modeling of Batrachochytrium dendrobatidis infection of the amphibian skin PLOS ONE Dear Mrs Verbrugghe, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers enjoyed the manuscript and thought it appropriate for PLOS One. Both also had some minor suggestions to clarify some points. Please address these points directly in the paper or in a reply where suitable. We would appreciate receiving your revised manuscript by Nov 16 2019 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Jake Kerby, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): Both reviewers enjoyed the manuscript and thought it appropriate for PLOS One. Both also had some minor suggestions to clarify some points. Please address these points directly in the paper or in a reply where suitable. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this manuscript by Verbrugghe et al., the authors describe the development of in vitro methods for studying the pathogen Batrachochytrium dendrobatidis (Bd) and its interactions with amphibian hosts. Specifically, the investigators developed models with epithelial cell lines for in vitro experimentation with Bd. The found that they could successfully develop keratinocytes from Litoria caerulea and kidney epithelial cells from Xenopus laevis. As this is an extrememly important area of research, I believe this paper will make a valuable contribution to the literature. I cannot comment extensively on the methods for maintaining cell lines (for the skin and kidney epithelia) but the microscopy suggests that this approach will be very valuable (if it can be replicated) for understanding early pathogenesis of chytridiomycosis. I have mostly minor comments: Line 38- I believe stratum corneum should be in italics. Line 40- Is the Bletz et al. reference appropriate here? Line 43- Is this a paragraph break? If not, it should be. Line 45- Change to "levels" (plural). Lines 52-54 - I know a number of researchers that would dispute the notion that "surprisingly few studies have tackled this disease's pathogenesis". The authors make this comment at multiple points in the paper and it may bolster their argument to clarify that they are referring to molecular and cellular mechanisms of *early* pathogenesis. On this particular point (in line 52), it may make sense to include additional papers on pathogenesis of this disease (e.g., Carver et al. 2010, Marcum et al. 2010, Voyles et al. 2007) Moreover, it appears there are a number of papers on pathogenesis and pathophysiology that the authors may have missed. As such, it may be worthwhile to review and include the following papers: Bovo, R.P., Andrade, D.V., Toledo, L.F., Longo, A.V., Rodriguez, D., Haddad, C.F., Zamudio, K.R. and Becker, C.G., 2016. Physiological responses of Brazilian amphibians to an enzootic infection of the chytrid fungus Batrachochytrium dendrobatidis. Diseases of aquatic organisms, 117(3), pp.245-252. Cramp, R.L., McPhee, R.K., Meyer, E.A., Ohmer, M.E. and Franklin, C.E., 2014. First line of defence: the role of sloughing in the regulation of cutaneous microbes in frogs. Conservation physiology. Grogan, L.F., Skerratt, L.F., Berger, L., Cashins, S.D., Trengove, R.D. and Gummer, J.P., 2018. Chytridiomycosis causes catastrophic organism-wide metabolic dysregulation including profound failure of cellular energy pathways. Scientific reports, 8(1), p.8188. Ohmer, M.E., Cramp, R.L., White, C.R. and Franklin, C.E., 2015. Skin sloughing rate increases with chytrid fungus infection load in a susceptible amphibian. Functional Ecology, 29(5), pp.674-682. Russo, C.J., Ohmer, M.E., Cramp, R.L. and Franklin, C.E., 2018. A pathogenic skin fungus and sloughing exacerbate cutaneous water loss in amphibians. Journal of Experimental Biology, 221(9), p.jeb167445. Wu, N.C., Cramp, R.L., Ohmer, M.E. and Franklin, C.E., 2019. Epidermal epidemic: unravelling the pathogenesis of chytridiomycosis. Journal of Experimental Biology, 222(2). Young, S., Speare, R., Berger, L. and Skerratt, L.F., 2012. Chloramphenicol with fluid and electrolyte therapy cures terminally ill green tree frogs (Litoria caerulea) with chytridiomycosis. Journal of Zoo and Wildlife Medicine, 43(2), pp.330-337. Line 58- This sentence is incomplete. It seems to be missing a verb. Line 64- Perhaps it is semantics but I wonder if the term "colonization" is more appropriate than "infection" at various points of this paper? Methods- A small point of preference - I recommend changing from passive voice to active voice throughout the methods. Lines 128-132 For the audiences that will be reading this paper, I recommend providing references for these methods. Lines 195-197- This sentence should be moved to the conclusions Lines 261- I suggest changing "infections" to "diseases" Lines 266- Change "chytrid" to "Bd and Bsal" because there are many chytrids that are not pathogens of amphibians. Lines 275- I suggest changing to "This obstacle was circumvented...." Lines 277- Same comment regarding the word "chytrid" Reviewer #2: It is clear that this project required a lot of very meticulous work, so kudos to the authors! This new model will be a great resource for Bd research on interactions between Bd and host cells. I only had one concern regarding the limitations of the in vitro model, which doesn’t detract from the value of the model, but could be acknowledged more clearly. Regarding the current study and references to the previous skin explant study, it seems that epibiotic growth may be related to the in vitro conditions, such as potentially some nutrients floating outside the cells in the culture medium and/or lack of a normal mucus layer that contains inhibitory bacteria and secretions. Thus, I am not sure that it is safe to assume that epibiotic growth occurs in nature (or at least occurs commonly), and this could influence conclusions made based on in vitro studies. Another example of the in vitro conditions potentially influencing the life cycle of Bd in a way that could contrast with natural conditions could be the observation of cell death from zoosporangia discharging zoospores into the same host cell rather than to the cell surface. This could be from lack of normal cell layer orientation in vitro or another factor that is related to the in vitro conditions. While the observation of cell death from Bd makes sense, a more common mechanism in nature might be from colonization from many zoosporangia. Again, the in vitro conditions may be influencing the reinfection process in a way that does not fully replicate natural conditions. Line 277: It might be useful to include the information about why PAK are useful for tracking the early infection process earlier in the paper, in the methods section, so the reader understands why these cells are not used to track the whole infection process. Since PLOS ONE encourages authors to publish detailed protocols as supporting information, it seems that this would be appropriate for this paper, since the protocols are pretty complicated. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
In vitro modeling of Batrachochytrium dendrobatidis infection of the amphibian skin PONE-D-19-18607R1 Dear Dr. Verbrugghe, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Jake Kerby, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Thanks for making the changes. These all look great! |
| Formally Accepted |
|
PONE-D-19-18607R1 In vitro modeling of Batrachochytrium dendrobatidis infection of the amphibian skin Dear Dr. Verbrugghe: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Jake Kerby Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .